Current practice in identifying and treating cardiovascular risk, with a focus on residual risk associated with atherogenic dyslipidaemia

statement of authorship
Roberto Ferrari, Carlos Aguiar, Eduardo Alegria, Riccardo C. Bonadonna,Francesco Cosentino, Moses Elisaf, Michel Farnier, Jean Ferrieres,Pasquale Perrone Filardi, Nicolae Hancu, Meral Kayikcioglu, Alberto Mello e Silva, Jesus Millan, Željko Reiner, Lale Tokgozoglu, Paul Valensi, Margus Viigimaa, Michal Vrablik, Alberto Zambon, Jose Luis Zamorano, and Alberico L. Catapano
source
European heart journal. Supplements : journal of the European Society of Cardiology
journal volume number month
vol. 18, suppl. C
year of publication
pages
p. C2-C12 : ill
ISSN
1520-765X
notes
bibliogr.: 56 ref
Open Access
Open Access
scientific publication
teaduspublikatsioon
language
inglise
keyword
atherogenic dyslipidaemia
residual cardiovascular risk
statin
fenofibrate
fenofibrate-statin
combination therapy
Ferrari, R., Aguiar, C., Alegria, E., Viigimaa, M. et al. Current practice in identifying and treating cardiovascular risk, with a focus on residual risk associated with atherogenic dyslipidaemia // European heart journal. Supplements : journal of the European Society of Cardiology (2016) vol. 18, suppl. C, p. C2-C12 : ill. https://doi.org/10.1093/eurheartj/suw009